Characterization of humoral and cellular immunity for tick-borne encephalitis (TBE) vaccination in allogeneic blood and marrow graft recipients: a pilot study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2018
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Therapeutic Use
- 12 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Dec 2017 Planned End Date changed from 1 Apr 2018 to 1 Dec 2018.
- 17 Dec 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Dec 2018.